These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19043733)

  • 1. Toxicities and pharmacokinetics of subconjunctival injection of liposomal amphotericin B.
    Kaji Y; Yamamoto E; Hiraoka T; Oshika T
    Graefes Arch Clin Exp Ophthalmol; 2009 Apr; 247(4):549-53. PubMed ID: 19043733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity and pharmacokinetics of intrastromal injection of amphotericin B in a rabbit model.
    Qu L; Li L; Xie H
    Curr Eye Res; 2014 Apr; 39(4):340-7. PubMed ID: 24215098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model.
    Cannon JP; Fiscella R; Pattharachayakul S; Garey KW; De Alba F; Piscitelli S; Edward DP; Danziger LH
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2112-7. PubMed ID: 12714650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model.
    Qu L; Li L; Xie H
    Ophthalmic Res; 2010; 43(3):153-8. PubMed ID: 19887881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal concentrations following systemic administration of amphotericin B and its lipid preparations in a rabbit model.
    Goldblum D; Rohrer K; Frueh BE; Theurillat R; Thormann W; Zimmerli S
    Ophthalmic Res; 2004; 36(3):172-6. PubMed ID: 15103209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):828-33. PubMed ID: 11850268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits.
    Clemons KV; Sobel RA; Williams PL; Stevens DA
    Antimicrob Agents Chemother; 2001 Feb; 45(2):612-5. PubMed ID: 11158765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctiva Necrosis Following Subconjunctival Amphotericin B Injection in Fungal Keratitis.
    Han Shu T; Hussein A; Kursiah MR
    Cureus; 2019 Sep; 11(9):e5580. PubMed ID: 31695999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities.
    Ramaswamy M; Peteherych KD; Kennedy AL; Wasan KM
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1184-91. PubMed ID: 11257033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):834-40. PubMed ID: 11850269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity and pharmacokinetics of subconjunctival amphotericin B. An experimental study.
    O'Day DM; Smith R; Stevens JB; Williams TE; Robinson RD; Head WS
    Cornea; 1991 Sep; 10(5):411-7. PubMed ID: 1935140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs.
    Nieto J; Alvar J; Rodríguez C; San Andrés MI; San Andrés MD; González F
    Res Vet Sci; 2018 Apr; 117():125-132. PubMed ID: 29272720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model.
    Goldblum D; Rohrer K; Frueh BE; Theurillat R; Thormann W; Zimmerli S
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3719-23. PubMed ID: 12435667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats.
    Risovic V; Boyd M; Choo E; Wasan KM
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3339-42. PubMed ID: 14506053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B.
    Loo AS; Muhsin SA; Walsh TJ
    Expert Opin Drug Saf; 2013 Nov; 12(6):881-95. PubMed ID: 23931455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of Amphotericin B in Rabbit Corneal Epithelial Cells Stored in Optisol™-GS: Corneal Epithelial Cell Morphology and Migration.
    Harada K; Fukuoka H; Ban Y; Aziza Y; Horiguchi G; Tanioka H; Kinoshita S; Uematsu M; Kitaoka T; Sotozono C
    Curr Eye Res; 2022 Sep; 47(9):1259-1265. PubMed ID: 35708189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.
    Petit C; Chéron M; Joly V; Rodrigues JM; Bolard J; Gaboriau F
    J Antimicrob Chemother; 1998 Dec; 42(6):779-85. PubMed ID: 10052902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models.
    Usman F; Nopparat J; Javed I; Srichana T
    Drug Deliv Transl Res; 2020 Feb; 10(1):59-69. PubMed ID: 31368043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774.
    Chéron M; Petit C; Bolard J; Gaboriau F
    J Antimicrob Chemother; 2003 Dec; 52(6):904-10. PubMed ID: 14613963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency.
    Burgess BL; He Y; Baker MM; Luo B; Carroll SF; Forte TM; Oda MN
    Int J Nanomedicine; 2013; 8():4733-43. PubMed ID: 24379661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.